As promotional strategies for FDA-regulated products have evolved rapidly in recent years to incorporate new media channels, government regulators have been trying to keep pace. Recently issued guidance and warning letters show a strong new regulatory focus on online marketing, however it is often unclear how the relevant rules apply to practices like Internet search ads, promotion on blogs and social networking sites, and testimonials.
American Conference Institute’s 8th Expert Regulatory Guide to Advertising, eMarketing and Promotions for the Pharmaceutical Industry will provide the guidance that is greatly needed by the life sciences industry at a time of transition. Companies do not want to miss out on the great opportunities presented by the huge popularity of social media, and other web sites where products may be discussed and promoted. The use of these new promotional channels, however, presents complex compliance questions and risks potential exposure to government inquiry.
With the FDA handing out warning letters recently “like candy,” it is essential to have sophisticated knowledge of the applicable regulatory requirements and specifi c “red fl ags” that you need to watch out for. The expert faculty at ACI’s timely conference, including in-house experts from 14 different companies, will directly address how to ensure that you are using the best available practices to operate safely in your advertising and promotional activities (in both traditional and nontraditional areas). You will be able to compare how your peers at other companies are applying the current rules in practice to different types of advertising and promotions. The faculty includes government and regulatory specialists who focus on the intersection between FDA law and marketing issues, and who are resolving these challenges daily. The program will provide up to the minute updates on state and federal legislation, regulatory guidance, and recent enforcement trends that are vital to understand in order to control your risks when mounting successful promotional programs today.
Special focus will be placed on particular areas that companies are seeking guidance on, including:
- How to ensure proper disclosure of risk information in a small ad on the internet
- Safely informing consumers about products on web sites, and correcting false information
- Anticipating what types of conduct might lead to allegations of off-label promotion
- Making use of athletes and other celebrities as spokespeople making product testimonials
- Preparing effectively for potential outcomes from the recent FDA meeting in Washington on Internet marketing
Add value to your experience with our Pre-Conference Workshop: FDA Regulatory Boot Camp on DTC Advertising. You will obtain an essential underlying framework for being able to develop and review marketing and promotional programs that avoid triggering potential FDA review.Register now by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online at www.americanconference.com/pharmaadvertising
Conference Details
